| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,772 |
7,480 |
$286K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,838 |
3,821 |
$257K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,197 |
5,998 |
$213K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,086 |
8,333 |
$208K |
| 86328 |
|
5,605 |
5,469 |
$195K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,161 |
3,130 |
$169K |
| 99215 |
Prolong outpt/office vis |
1,343 |
1,289 |
$78K |
| 99205 |
Prolong outpt/office vis |
596 |
596 |
$51K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,967 |
2,885 |
$49K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,829 |
1,759 |
$21K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
992 |
931 |
$17K |
| 99417 |
Prolong home eval add 15m |
583 |
583 |
$16K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
433 |
423 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
578 |
570 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
212 |
212 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
151 |
82 |
$1K |
| 81005 |
|
780 |
768 |
$1K |
| 87400 |
|
228 |
227 |
$1K |
| 94760 |
|
207 |
203 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
112 |
112 |
$718.76 |
| 81000 |
|
259 |
250 |
$647.77 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
47 |
47 |
$229.26 |
| S9083 |
Global fee urgent care centers |
126 |
123 |
$90.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
125 |
124 |
$82.76 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
118 |
118 |
$75.00 |
| 81003 |
|
14 |
14 |
$19.40 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
15 |
$12.45 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
40 |
40 |
$4.66 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
14 |
14 |
$3.76 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
23 |
22 |
$2.99 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
64 |
64 |
$2.21 |
| 99401 |
|
25 |
21 |
$0.00 |